Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 24

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 24
---
 of Ordinary Shares represented by the Depositary Shares for which the warrant is exercisable immediately
prior to such fundamental transaction.

Transferability.
Each warrant and all rights thereunder are transferable, in whole or in part, upon surrender of the warrant, together with a written assignment
of the warrant subject to applicable securities laws; provided, however, that the Wainwright May Warrants are subject to certain FINRA
transfer restrictions. We do not intend to apply for listing of the warrants on any securities exchange or other trading system.

No Rights as Shareholder Until Exercise. Except as set forth in the warrants, the holders of the warrants do not have any voting rights,
dividends or other rights as a holder of our capital stock until they exercise the warrants.

May 2020 United Kingdom Placing Warrants

On May 22, 2020, we issued
333,333 units, with each unit comprising one new ordinary share and one warrant to purchase one new Ordinary Share, or a UK Warrant. The
exercise price of the UK Warrants is £6.80 per share, and they expire five years and six months from the issuance date. We also
issued UK Warrants to purchase a total of 16,400 Ordinary Shares to Turner Pope, the placing agent, in connection with the closing of
such offering, on the same terms and conditions as the other investors in the offering.

| 19 |

August 2022 Warrants

On August 3, 2022, we issued
warrants to purchase 16,400 Ordinary Shares to Strand Hanson Limited, in payment for services rendered. The exercise price of such warrants
is £2.70 per share and they expire three years from the issuance date.

February Placement Agent Warrants

The
following is a brief summary of the warrants issued to a placement agent issued in connection with the February Private Placement and
is subject in all respects to the provisions contained in the warrant, which is filed as an exhibit to Registration Statement on Form
F-1.

Exercisability.
The February Placement Agent Warrants are exercisable and expire three years from the initial exercise date. The holder shall deliver
the aggregate exercise price for the Depositary Shares specified in the exercise notice within two trading days following the date of
exercise (subject to the ‘cashless exercise’ arrangements described below).

Cashless Exercise. The February Placement Agent Warrants may only be exercised on a cashless basis if, following a date that is six months
from the original